Skip to content
10-Q

Quarterly Report

EMERGENT BIOSOLUTIONS INC. EBS

0001367644-25-000202

← back to feed
Filed
Oct 30, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 22, 2025 52.52M sh
Shares Diluted Q3 2025 · Sep 30, 2025 56.5M sh
Shares Diluted Q3 2025 · Sep 30, 2025 56.7M sh
Shares Diluted Q3 2025 · Sep 30, 2024 55.6M sh
Shares Diluted Q3 2025 · Sep 30, 2024 52.6M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $15.8M
Stock Repurchased Q3 2025 · Sep 30, 2024 $0
Capex Q3 2025 · Sep 30, 2025 $9.9M
Capex Q3 2025 · Sep 30, 2024 $21.2M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $92.9M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $138.6M
Long Term Debt Q3 2025 · Sep 30, 2025 $663.1M
Long Term Debt Q3 2025 · Dec 31, 2024 $663.7M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $245.5M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $99.5M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $149.9M
Stockholders Equity Q3 2025 · Sep 30, 2025 $582.5M
Stockholders Equity Q3 2025 · Jun 30, 2025 $536.2M
Stockholders Equity Q3 2025 · Mar 31, 2025 $552.7M
Stockholders Equity Q3 2025 · Dec 31, 2024 $482.8M
Stockholders Equity Q3 2025 · Sep 30, 2024 $508.4M
Stockholders Equity Q3 2025 · Jun 30, 2024 $386.3M
Stockholders Equity Q3 2025 · Mar 31, 2024 $663.9M
Stockholders Equity Q3 2025 · Dec 31, 2023 $649.3M
Current Liabilities Q3 2025 · Sep 30, 2025 $136.5M
Current Liabilities Q3 2025 · Dec 31, 2024 $162.4M
Total Liabilities Q3 2025 · Sep 30, 2025 $878.5M
Total Liabilities Q3 2025 · Dec 31, 2024 $906.9M
Current Assets Q3 2025 · Sep 30, 2025 $786.9M
Current Assets Q3 2025 · Dec 31, 2024 $598.7M
Total Assets Q3 2025 · Sep 30, 2025 $1.46B
Total Assets Q3 2025 · Dec 31, 2024 $1.39B
Eps Diluted Q3 2025 · Sep 30, 2025 $0.91
Eps Diluted Q3 2025 · Sep 30, 2025 $1.89
Eps Diluted Q3 2025 · Sep 30, 2024 $2.06
Eps Diluted Q3 2025 · Sep 30, 2024 −$3.03
Eps Basic Q3 2025 · Sep 30, 2025 $0.96
Eps Basic Q3 2025 · Sep 30, 2025 $1.99
Eps Basic Q3 2025 · Sep 30, 2024 $2.16
Eps Basic Q3 2025 · Sep 30, 2024 −$3.03
Sga Expense Q3 2025 · Sep 30, 2025 $38.9M
Sga Expense Q3 2025 · Sep 30, 2025 $135M
Sga Expense Q3 2025 · Sep 30, 2024 $76.6M
Sga Expense Q3 2025 · Sep 30, 2024 $247.2M
Rd Expense Q3 2025 · Sep 30, 2025 $13.5M
Rd Expense Q3 2025 · Sep 30, 2025 $41.1M
Rd Expense Q3 2025 · Sep 30, 2024 $13.8M
Rd Expense Q3 2025 · Sep 30, 2024 $61.6M
Net Income Q3 2025 · Sep 30, 2025 $51.2M
Net Income Q3 2025 · Sep 30, 2025 $107.2M
Net Income Q3 2025 · Jun 30, 2025 −$12M
Net Income Q3 2025 · Mar 31, 2025 $68M
Net Income Q3 2025 · Sep 30, 2024 $114.8M
Net Income Q3 2025 · Sep 30, 2024 −$159.3M
Net Income Q3 2025 · Jun 30, 2024 −$283.1M
Net Income Q3 2025 · Mar 31, 2024 $9M
Operating Income Q3 2025 · Sep 30, 2025 $76.5M
Operating Income Q3 2025 · Sep 30, 2025 $128M
Operating Income Q3 2025 · Sep 30, 2024 $64.5M
Operating Income Q3 2025 · Sep 30, 2024 −$99.2M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $85.9M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $241.3M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $122.6M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $563.3M
Revenue Q3 2025 · Sep 30, 2025 $231.1M
Revenue Q3 2025 · Sep 30, 2025 $594.2M
Revenue Q3 2025 · Sep 30, 2024 $293.8M
Revenue Q3 2025 · Sep 30, 2024 $848.9M